Health Guide

<![CDATA[ The *Daily Mail* has reported that doctors do not support giving life-extending drugs to patients with terminal cancer. The newspaper says that a new report has said the treatments “give false hope and are […]

<![CDATA[ Research at the Malaghan Institute of Medical Research has highlighted a process by which children might become allergic to peanuts, without ever tasting them. Prof Graham Le Gros, Director of the Malaghan Institute, leads

<![CDATA[ An inexpensive stop-smoking drug popular in Eastern Europe was significantly more effective than placebo in a randomized trial, but not by very much, researchers said. In a 740-person trial conducted in Poland, 8.4% of

<![CDATA[Access Pharmaceuticals, Inc. (OTC:ACCP), announced findings of an independent presentation on MuGard clinical experience. The ongoing research study was conducted by the Oncology and Maxillofacial Departments of the Musgrove Park Hospital in Taunton, UK. In

<![CDATA[ Medical groups of all types and sizes stand collectively at a crossroads in the evolution of the healthcare industry in the United States at this point in time. Faced with a welter of issues,

<![CDATA[ Business Monitor International’s (BMI) Romania Pharmaceuticals and Healthcare Report (Q4 2011) provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Romania’s pharmaceuticals

<![CDATA[ CANCER Council’s Southern Region has welcomed a $28 million transport and accommodation boost for regional patients. The improvement to the government’s Isolated Patients Travel and Accommodation Assistance Scheme (IPTAAS) will see thousands of cancer

<![CDATA[ The National Institutes of Health Clinical Center began imaging patients last week on a first-of-its-kind, whole-body simultaneous positron emission topography (PET) and magnetic resonance imaging (MRI) device. The Biograph mMR offers a more complete

<![CDATA[ The National Institutes of Health has awarded $3.8 million to the University of California, Davis, to fund a new mouse-based research center devoted to studies of the physiology and genetics of obesity, diabetes and

<![CDATA[ A mist inhaler with the drug Spiriva is associated with a 52 percent increased risk of death among people with chronic obstructive pulmonary disease (COPD), a new review shows. The mist inhaler with the